ArkeaBio vs DeHaat
Side-by-side comparison of AI visibility scores, market position, and capabilities
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
About
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
DeHaat is India's leading full-stack agritech platform connecting small farmers to inputs, advisory, and markets — $222M raised, $900M+ valuation, acquired AgriCentral in Jan 2025, expanding to South India.
About
DeHaat (operated by Agrevolution) is an India-based full-stack agricultural technology company providing end-to-end services to small and marginal farmers across the agricultural value chain. Founded in 2012 in Patna, Bihar, DeHaat connects farmers to input suppliers (seeds, fertilizers, agrochemicals), AI-driven crop advisory, soil testing, pest management guidance, financial services, and market linkages — all through its mobile app and a network of local micro-entrepreneur agents called DeHaat Centers.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.